Workflow
国药现代(600420) - 2025 Q3 - 季度财报
SHYNDECSHYNDEC(SH:600420)2025-10-29 08:35

Financial Performance - The company's operating revenue for Q3 2025 was ¥2,042,719,648.45, a decrease of 22.43% year-on-year[5] - The total profit for the period was ¥190,562,105.19, down 48.54% compared to the same quarter last year[5] - Net profit attributable to shareholders was ¥129,104,688.63, reflecting a decline of 45.31% year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥102,282,542.35, a significant drop of 58.01% compared to the previous year[5] - The basic and diluted earnings per share were both ¥0.0963, down 45.28% year-on-year[5] - Total operating revenue for the first three quarters of 2025 was CNY 6.92 billion, a decrease of 19.5% compared to CNY 8.59 billion in the same period of 2024[20] - Net profit for the first three quarters of 2025 was CNY 933.23 million, a decline of 22.2% from CNY 1.20 billion in 2024[21] - Operating profit for the first three quarters of 2025 was CNY 1.10 billion, down 25.0% from CNY 1.47 billion in the previous year[21] - Basic earnings per share for the first three quarters of 2025 were CNY 0.5974, down from CNY 0.7117 in 2024[22] Assets and Liabilities - The company's total assets at the end of the reporting period were ¥19,330,801,003.68, a decrease of 3.13% from the end of the previous year[6] - The company's current assets totaled RMB 10,799,627,521.67, down from RMB 11,684,104,124.22, indicating a decrease of about 7.53%[16] - Total liabilities decreased to RMB 3,632,219,485.35 from RMB 4,633,633,097.68, a reduction of about 21.59%[17] - The company's equity attributable to shareholders increased to RMB 13,638,317,886.42 from RMB 13,203,924,172.51, an increase of approximately 3.29%[18] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥1,141,629,735.11, down 43.66% year-on-year[5] - Cash flow from operating activities generated CNY 1.14 billion, a decrease of 43.7% compared to CNY 2.03 billion in 2024[25] - The net cash flow from investment activities was negative at CNY 1.67 billion, worsening from a negative CNY 1.35 billion in 2024[25] - In the first three quarters of 2025, the net cash flow from financing activities was -$1.64 billion, compared to -$407.06 million in the same period of 2024[26] - The total cash outflow from financing activities in the first three quarters of 2025 was $1.64 billion, significantly higher than $457.06 million in 2024[26] Expenses - Total operating costs decreased to CNY 5.86 billion, down 18.0% from CNY 7.15 billion year-over-year[20] - Research and development expenses for the first three quarters of 2025 were CNY 331.63 million, a reduction of 20.3% from CNY 416.21 million in 2024[20] - Sales expenses significantly decreased to CNY 354.82 million, down 63.4% from CNY 969.12 million year-over-year[20] Market Factors - The decline in profits was attributed to industry cycles, market competition, and reduced demand for key products[9] - The company reported a significant increase in non-recurring gains and losses, impacting the net profit figures[10] Cash and Equivalents - Cash and cash equivalents decreased to RMB 4,141,241,012.60 from RMB 6,211,941,467.03, representing a decline of approximately 33.39%[15] - The cash and cash equivalents at the end of Q3 2025 were $3.99 billion, down from $5.42 billion at the end of Q3 2024[26] - The net increase in cash and cash equivalents for the first three quarters of 2025 was -$2.16 billion, while it was $289.39 million in the same period of 2024[26] - The impact of exchange rate changes on cash and cash equivalents was $18.64 million in 2025, compared to $24.55 million in 2024[26]